Oxygen-generating compositions for enhancing cell and tissue survival in vivo

Patent metadata

Field	Value
Publication number	US-10493040-B2
Application number	US-53252008-A
Country	US
Kind code	B2
Filing date	Apr 8, 2008
Priority date	Apr 9, 2007
Publication date	Dec 3, 2019
Grant date	Dec 3, 2019

Abstract

A method of treating hypoxic tissue such as wound tissue comprises contacting a composition to the hypoxic tissue in a hypoxia-treatment effective amount, the composition comprising a biodegradable polymer and an inorganic peroxide incorporated into the polymer.

First claim

That which is claimed is:

1. A method of treating hypoxic tissue in need thereof, comprising contacting an oxygen-generating composition to said hypoxic tissue,
said composition comprising a biodegradable polymeric film and an oxygen-generating inorganic peroxide incorporated into said polymeric film,
wherein said oxygen-generating inorganic peroxide comprises a plurality of solid oxygen-generating inorganic peroxide particles that are selected from calcium peroxide, magnesium peroxide and/or sodium percarbonate,
wherein said oxygen-generating inorganic peroxide particles generate oxygen, and said oxygen contacts said hypoxic tissue in a hypoxia-treatment oxygenation effective amount to oxygenate said hypoxic tissue, thereby treating said hypoxic tissue,
wherein said contacting comprises implanting said oxygen-generating composition into a subject in need of said treatment, and
wherein said hypoxic tissue is in vivo in the subject in need of said treatment.

2. The method of claim 1 , wherein said tissue is wound tissue and said composition is administered in an amount effective to facilitate the healing of said wound tissue.

3. The method of claim 1 , wherein said tissue is afflicted with an anaerobic infection and said composition is administered in an amount effective to treat said infection.

4. The method of claim 1 , wherein said composition is in the form of a sheet material, and said contacting step is carried out by contacting said sheet material to said tissue.

5. The method of claim 1 , wherein said composition is in the form of a surgical or paramedical aid, and said contacting step is carried out by contacting said aid to said tissue.

6. The method of claim 1 , wherein said biodegradable polymeric film comprises a polymer selected from the group consisting of polylactide, polyglycolide, poly lactide-glycolide copolymers, polycaprolactone, and alginate.

7. The method of claim 1 , wherein said plurality of solid oxygen-generating inorganic peroxide particles is comprised of calcium peroxide.

8. The method of claim 1 , wherein said plurality of solid oxygen-generating inorganic peroxide particles is comprised of sodium percarbonate.

9. The method of claim 1 , wherein said composition comprises:
(a) from 70 to 99 percent by weight of said biodegradable polymeric film; and
(b) from 1 to 30 percent by weight of said oxygen-generating inorganic peroxide particles.

10. A method of treating hypoxic tissue in need thereof, comprising contacting an oxygen-generating composition to said hypoxic tissue, wherein said composition comprises:
(a) from 70 to 99 percent by weight of a biodegradable polymeric film, said biodegradable polymeric film comprising a polymer selected from the group consisting of polylactide, polyglycolide, poly lactide-glycolide copolymers, polycaprolactone, and alginate;
(b) from 1 to 30 percent by weight of an inorganic peroxide incorporated into said polymeric film, wherein said inorganic peroxide comprises a plurality of solid inorganic peroxide particles that are selected from the group consisting of calcium peroxide, magnesium peroxide, and sodium percarbonate;
(c) from 0.1 to 30 percent by weight of a radical trap or peroxide decomposition catalyst incorporated into the polymeric film in solid form, said radical trap or peroxide decomposition catalyst selected from the group consisting of iron, catalase, peroxidase, dehydrogenase, and cyclic salen-metals; and
(d) from 0.001 to 5 percent by weight of at least one additional active agent selected from the group consisting of antibiotics, steroids, anti-inflammatory agents, keratolytics, and growth factors,
wherein the inorganic peroxide generates oxygen, and said oxygen contacts said hypoxic tissue in a hypoxia-treatment oxygenation effective amount to oxygenate said hypoxic tissue, thereby treating said hypoxic tissue.

11. The method of claim 10 , wherein said plurality of solid inorganic peroxide particles is comprised of calcium peroxide.

12. The method of claim 10 , wherein said plurality of solid inorganic peroxide particles is comprised of sodium percarbonate.

13. The method of claim 10 , wherein said contacting comprises implanting said oxygen-generating composition into a subject in need of said treatment.

14. The method of claim 1 , wherein said oxygen-generating composition is implanted in vivo as a tissue scaffold.

15. The method of claim 1 , wherein said composition consists essentially of said biodegradable polymeric film, said oxygen-generating inorganic peroxide, optionally a radical trap or peroxide decomposition catalyst, and optionally at least one additional active agent selected from the group consisting of antibiotics, steroids, anti-inflammatory agents, keratolytics, and growth factors.

Assignees

• Harrison Benjamin S
• Yoo James J
• Atala Anthony
• Univ Wake Forest Health Sciences

Inventors

• Harrison Benjamin S
• Yoo James J
• Atala Anthony

Classifications

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A61P31/04

  Antibacterial agents · CPC title

• A61P17/02

  for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title

• A61L27/446

  with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46 · CPC title